These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33356385)

  • 1. Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles.
    Vazquez-Prada KX; Lam J; Kamato D; Xu ZP; Little PJ; Ta HT
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):601-613. PubMed ID: 33356385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
    Wang X; Peter K
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of cardiovascular disease.
    Jaffer FA; Libby P; Weissleder R
    Circulation; 2007 Aug; 116(9):1052-61. PubMed ID: 17724271
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 5. The advancing clinical impact of molecular imaging in CVD.
    Osborn EA; Jaffer FA
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1327-41. PubMed ID: 24332285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis.
    Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ
    J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality Molecular Imaging of Cardiovascular Disease Based on Nanoprobes.
    Tu Y; Sun Y; Fan Y; Cheng Z; Yu B
    Cell Physiol Biochem; 2018; 48(4):1401-1415. PubMed ID: 30064129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
    Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
    Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Imaging for Cell Death in Cardiovascular Disorders.
    Shekhar A; Heeger P; Reutelingsperger C; Arbustini E; Narula N; Hofstra L; Bax JJ; Narula J
    JACC Cardiovasc Imaging; 2018 Mar; 11(3):476-493. PubMed ID: 29361478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular molecular imaging: an overview.
    Saraste A; Nekolla SG; Schwaiger M
    Cardiovasc Res; 2009 Sep; 83(4):643-52. PubMed ID: 19553359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of atherosclerosis with integrated PET imaging.
    Hammad B; Evans NR; Rudd JHF; Tawakol A
    J Nucl Cardiol; 2017 Jun; 24(3):938-943. PubMed ID: 28078575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
    Qiao R; Huang X; Qin Y; Li Y; Davis TP; Hagemeyer CE; Gao M
    Nanoscale; 2020 Apr; 12(15):8040-8064. PubMed ID: 32239038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Risk in Multisystem Inflammatory Diseases.
    Ikonomidis I; Makavos G; Katsimbri P; Boumpas DT; Parissis J; Iliodromitis E
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2517-2537. PubMed ID: 30878436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From myocardium to the atherosclerotic plaque: new perspectives in cardiologic imaging].
    Gargiulo P; D'Amore C; Dellegrottaglie S; Leosco D; Rengo G; Musella F; Pirozzi E; Mosca S; Casaretti L; Formisano R; Bologna A; Parente A; Conte S; Perrone-Filardi P
    Monaldi Arch Chest Dis; 2011 Jun; 76(2):60-5. PubMed ID: 22128608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
    den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
    Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.
    Bejarano J; Navarro-Marquez M; Morales-Zavala F; Morales JO; Garcia-Carvajal I; Araya-Fuentes E; Flores Y; Verdejo HE; Castro PF; Lavandero S; Kogan MJ
    Theranostics; 2018; 8(17):4710-4732. PubMed ID: 30279733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
    Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.
    Palekar RU; Jallouk AP; Lanza GM; Pan H; Wickline SA
    Nanomedicine (Lond); 2015; 10(11):1817-32. PubMed ID: 26080701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging of cardiac remodelling after myocardial infarction.
    Curley D; Lavin Plaza B; Shah AM; Botnar RM
    Basic Res Cardiol; 2018 Jan; 113(2):10. PubMed ID: 29344827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.